{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T04:40:40Z","timestamp":1768711240385,"version":"3.49.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":4230,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,2]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>In human alveolar echinococcosis (AE), benzimidazoles are given throughout life because they are only parasitostatic. It has been a longstanding goal to limit treatment, and recent reports suggest that, in selected cases, benzimidazoles may be parasitocidal. Previously, we showed that positron -emission tomography (PET) using [<jats:sup>18<\/jats:sup>F]fluoro-deoxyglucose discriminates active from inactive lesions in AE. We have now performed a 3-year prospective study in 23 patients and conducted a structured treatment interruption in those without signs of PET activity. Disease progression was further assessed by ultrasound, computerized tomography, laboratory parameters, and clinical examination.We found PET-negative lesions in 15 of 23 patients and benzimidazoles were discontinued in these patients. After 18 months, patients were reevaluated, and, of the 15 initially PET-negative patients, 8 showed either new activity on PET (n = 6) or signs of clinical progression (n = 2). Reinitiation of benzimidazoles halted parasite growth again. No further progression was detected after 36 months. PET had a sensitivity of 91% for the detection of active lesions. In conclusion, despite successful suppression of metabolic activity, in most cases benzimidazoles do not kill the parasite. PET is a reliable tool for assessing metabolic activity and for timely detection of relapses. Neither duration of treatment, kind of treatment, lesion size, calcifications, or regressive changes reliably indicate parasite death. We discourage the discontinuation of benzimidazoles in inoperable AE even after many years of treatment. However, patients with a poor compliance of benzimidazole intake or patients suffering from side effects to benzimidazoles might be assessed for PET negativity. If permanent discontinuation of benzimidazoles is attempted, the course of disease should be followed by PET. (Hepatology 2004;39:509-517.)<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.20078","type":"journal-article","created":{"date-parts":[[2004,2,3]],"date-time":"2004-02-03T17:05:53Z","timestamp":1075827953000},"page":"509-517","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":150,"title":["Structured treatment interruption in patients with alveolar echinococcosis"],"prefix":"10.1097","volume":"39","author":[{"given":"Stefan","family":"Reuter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Buck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burkhard","family":"Manfras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Kratzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanns Martin","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kassa","family":"Darge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven Norbert","family":"Reske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-33-20241201","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/hep.510250305","article-title":"Effect of albendazole on recurrent and residual alveolar echinococcosis of the liver after surgery.","volume":"25","author":"Ishizu","year":"1997","journal-title":"HEPATOLOGY"},{"key":"R2-33-20241201","first-page":"231","article-title":"Guidelines for treatment of cystic and alveolar echinococcosis in humans.","volume":"74","year":"1996","journal-title":"Bull World Health Organ"},{"key":"R3-33-20241201","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/hep.1840190328","article-title":"Effect of chemotherapy on the larval mass and the long-term course of alveolar echinococcosis. Swiss Echinococcosis Study Group.","volume":"19","author":"Ammann","year":"1994","journal-title":"HEPATOLOGY"},{"key":"R4-33-20241201","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.4269\/ajtmh.1983.32.1381","article-title":"Serologic tests for diagnosis and post-treatment evaluation of patients with alveolar hydatid disease (Echinococcus multilocularis).","volume":"32","author":"Schantz","year":"1983","journal-title":"Am J Trop Med Hyg"},{"key":"R5-33-20241201","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/clinids\/15.2.234","article-title":"Parasiticidal effect of chemotherapy in alveolar hydatid disease: review of experience with mebendazole and albendazole in Alaskan Eskimos.","volume":"15","author":"Wilson","year":"1992","journal-title":"Clin Infect Dis"},{"key":"R6-33-20241201","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S0168-8278(98)80129-3","article-title":"Long-term mebendazole therapy may be parasitocidal in alveolar echinococcosis.","volume":"29","author":"Ammann","year":"1998","journal-title":"J Hepatol"},{"key":"R7-33-20241201","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s15010-001-1081-2","article-title":"Alveolar iver echinococcosis: a comparative study of three imaging techniques.","volume":"29","author":"ussle K, Kolokythas","year":"2001","journal-title":"Infection"},{"key":"R8-33-20241201","first-page":"1965","article-title":"Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy.","volume":"35","author":"Torizuka","year":"1994","journal-title":"J Nucl Med"},{"key":"R9-33-20241201","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0925-5710(97)00068-6","article-title":"Usefulness of FDG-PET in diagnosing primary lymphoma of the liver.","volume":"66","author":"Bangerter","year":"1997","journal-title":"Int J Hematol"},{"key":"R10-33-20241201","first-page":"42","article-title":"Assessment of tissue viability with fluorine-18-fluoro-2-deoxyglucose (FDG) and carbon-11-acetate PET imaging.","volume":"19","author":"Schroter","year":"1994","journal-title":"Herz"},{"key":"R11-33-20241201","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF03165391","article-title":"FDG-PET in infectious lesions: the detection and assessment of lesion activity.","volume":"10","author":"Ichiya","year":"1996","journal-title":"Ann Nucl Med"},{"key":"R12-33-20241201","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10096-002-0708-2","article-title":"Promising role of 18-F-fluoro-D-deoxyglucose positron emission tomography in clinical infectious diseases.","volume":"21","author":"De Winter","year":"2002","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R13-33-20241201","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S0140-6736(01)06491-1","article-title":"Finding infectionhelp from PET.","volume":"358","author":"Alavi","year":"2001","journal-title":"Lancet"},{"key":"R14-33-20241201","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s002590000277","article-title":"Infection imaging using whole-body FDG-PET.","volume":"27","author":"Stumpe","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"R15-33-20241201","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1086\/313438","article-title":"Pericystic metabolic activity in alveolar echinococcosis: assessment and follow-up by positron emission tomography.","volume":"29","author":"Reuter","year":"1999","journal-title":"Clin Infect Dis"},{"key":"R16-33-20241201","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1128\/jcm.31.2.373-376.1993","article-title":"Improved primary immunodiagnosis of alveolar echinococcosis in humans by an enzyme-linked immunosorbent assay using the Em2plus antigen.","volume":"31","author":"Gottstein","year":"1993","journal-title":"J Clin Microbiol"},{"key":"R17-33-20241201","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/BF00238116","article-title":"Improved iterative image reconstruction using variable projection binning and abbreviated convolution.","volume":"21","author":"Schmidlin","year":"1994","journal-title":"Eur J Nucl Med"},{"key":"R18-33-20241201","doi-asserted-by":"crossref","first-page":"506","DOI":"10.4269\/ajtmh.1990.43.506","article-title":"Recurrence rate after discontinuation of long-term mebendazole therapy in alveolar echinococcosis (preliminary results).","volume":"43","author":"Ammann","year":"1990","journal-title":"Am J Trop Med Hyg"},{"key":"R19-33-20241201","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/jac\/46.3.451","article-title":"Benzimidazoles in the treatment of alveolar echinococcosis: a comparative study and review of the literature.","volume":"46","author":"Reuter","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"R20-33-20241201","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/00034983.1986.11812041","article-title":"Consequences of continuous mebendazole therapy in alveolar hydatid diseasewith a summary of a ten-year clinical trial.","volume":"80","author":"Rausch","year":"1986","journal-title":"Ann Trop Med Parasitol"},{"key":"R21-33-20241201","first-page":"1016","article-title":"Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma.","volume":"39","author":"Higashi","year":"1998","journal-title":"J Nucl Med"},{"key":"R22-33-20241201","first-page":"333","article-title":"Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment.","volume":"33","author":"Okazumi","year":"1992","journal-title":"J Nucl Med"},{"key":"R23-33-20241201","first-page":"1811","article-title":"In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET.","volume":"36","author":"Torizuka","year":"1995","journal-title":"J Nucl Med"},{"key":"R24-33-20241201","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0009-9260(05)80311-3","article-title":"Alveolar hydatid disease of the liver: computed tomography and transabdominal ultrasound with histopathological correlation.","volume":"46","author":"Choji","year":"1992","journal-title":"Clin Radiol"},{"key":"R25-33-20241201","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1148\/radiology.154.1.3880602","article-title":"Hepatic alveolar echinococcosis: correlative US and CT study.","volume":"154","author":"Didier","year":"1985","journal-title":"Radiology"},{"key":"R26-33-20241201","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0035-9203(93)90048-U","article-title":"Computer tomography of liver in alveolar echinococcosis treated with albendazole.","volume":"87","author":"Liu","year":"1993","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R27-33-20241201","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1007\/BF01711918","article-title":"Long term course of alveolar echinococcosis in 60 patients treated by mebendazole (1976-1985). .","volume":"66","author":"Ammann","year":"1988","journal-title":"Klin Wochenschr"},{"key":"R28-33-20241201","doi-asserted-by":"crossref","first-page":"576","DOI":"10.4269\/ajtmh.1987.36.576","article-title":"Spontaneous death of Echinococcus multilocularis: cases diagnosed serologically (by Em2 ELISA) and clinical significance.","volume":"36","author":"Rausch","year":"1987","journal-title":"Am J Trop Med Hyg"},{"key":"R29-33-20241201","doi-asserted-by":"crossref","first-page":"734","DOI":"10.4269\/ajtmh.1991.45.734","article-title":"Specific cellular and humoral immune responses in patients with different long-term courses of alveolar echinococcosis (infection with Echinococcus multilocularis).","volume":"45","author":"Gottstein","year":"1991","journal-title":"Am J Trop Med Hyg"},{"key":"R30-33-20241201","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1128\/AAC.42.5.1052","article-title":"In vitro activities of benzimidazoles against Echinococcus multilocularis metacestodes.","volume":"42","author":"Jura","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"R31-33-20241201","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/00034983.1986.11812041","article-title":"Consequences of continuous mebendazole therapy in alveolar hydatid diseasewith a summary of a ten-year clinical trial.","volume":"80","author":"Rausch","year":"1986","journal-title":"Ann Trop Med Parasitol"},{"key":"R32-33-20241201","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1128\/AAC.47.2.620-625.2003","article-title":"Effect of amphotericin B on larval growth of Echinococcus multilocularis.","volume":"47","author":"Reuter","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"R34-33-20241201","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF00927740","article-title":"Collagen immunotyping of the hepatic fibrosis in human alveolar echinococcosis.","volume":"72","author":"Vuitton","year":"1986","journal-title":"Z Parasitenkd"},{"key":"R35-33-20241201","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.4049\/jimmunol.152.6.2660","article-title":"Changes in glucose transport and transporter isoforms during the activation of human peripheral blood lymphocytes by phytohemagglutinin.","volume":"152","author":"Chakrabarti","year":"1994","journal-title":"J Immunol"},{"key":"R36-33-20241201","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/jlb.59.5.639","article-title":"Augmentations of glucose uptake and glucose transporter-1 in macrophages following thermal injury and sepsis in mice.","volume":"59","author":"Gamelli","year":"1996","journal-title":"J Leukoc Biol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.20078","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200402000-00033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T12:10:28Z","timestamp":1733055028000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200402000-00033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.20078","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}